Dementia and Neurocognitive Disorders (대한치매학회지)

Korean Dementia Association (대한치매학회)
권호 표지
DOI QR코드

DOI QR Code

Association of Type 2 Diabetes Mellitus With Perivascular Spaces and Cerebral Amyloid Angiopathy in Alzheimer's Disease: Insights From MRI Imaging

  • Received : 2023.05.23
  • Accepted : 2023.06.24
  • Published : 2023.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Purpose: According to the amyloid cascade hypothesis, fibrillary amyloid-beta load in the brain causes Alzheimer's disease (AD) with toxic effects. Recently, perivascular spaces (PVSs), fluid-filled cavities around small penetrating arterioles and venules in the brain, and the glymphatic system relationship with type 2 diabetes mellitus (DM2) and AD has been an important research topic from a physiopathological point of view. There are two types of PVSs that are associated with sporadic atherosclerosis and cerebral amyloid angiopathy. In this study, we evaluated the relationship between the number and localization of enlarged PVSs in AD. Methods: A total of 254 patients with AD and 125 healthy controls were included in this study All the patients were evaluated with neurological and cognitive examinations and magnetic resonance imaging (MRI). PVSs on MRI were graded by recording their number and location. The study was a retrospective study. Results: In our study, the number of white matter convexity-central semiovale localized PVSs was higher in patients than in the control group. In addition, the number of PVSs in this localization score was higher in patients with DM2. Cerebral PVS counts were higher in patients with AD than in the control group. Conclusions: These results suggest the important role of cerebral amyloid angiopathy, one of the vascular risk factors, and the glymphatic system in the pathogenesis of AD. In addition, the results of our study suggest that the evaluation of PVSs levels, especially at the (centrum semiovale), using imaging studies in AD is a potential diagnostic option.

Keywords

References

  1. Marin-Padilla M, Knopman DS. Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases. J Neuropathol Exp Neurol 2011;70:1060-1069. https://doi.org/10.1097/NEN.0b013e31823ac627
  2. Ramirez J, Berezuk C, McNeely AA, Gao F, McLaurin J, Black SE. Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol 2016;36:289-299. https://doi.org/10.1007/s10571-016-0343-6
  3. Groeschel S, Chong WK, Surtees R, Hanefeld F. Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology 2006;48:745-754. https://doi.org/10.1007/s00234-006-0112-1
  4. Ding J, Sigurdsson S, Jonsson PV, Eiriksdottir G, Charidimou A, Lopez OL, et al. Large perivascular spaces visible on magnetic resonance imaging, cerebral small vessel disease progression, and risk of dementia: the age, gene/environment susceptibility-Reykjavik study. JAMA Neurol 2017;74:1105-1112. https://doi.org/10.1001/jamaneurol.2017.1397
  5. Zhu YC, Tzourio C, Soumare A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke 2010;41:2483-2490. https://doi.org/10.1161/STROKEAHA.110.591586
  6. Banerjee G, Kim HJ, Fox Z, Jager HR, Wilson D, Charidimou A, et al. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden. Brain 2017;140:1107-1116. https://doi.org/10.1093/brain/awx003
  7. Charidimou A, Hong YT, Jager HR, Fox Z, Aigbirhio FI, Fryer TD, et al. White matter perivascular spaces on magnetic resonance imaging: marker of cerebrovascular amyloid burden? Stroke 2015;46:1707-1709. https://doi.org/10.1161/STROKEAHA.115.009090
  8. Charidimou A, Jaunmuktane Z, Baron JC, Burnell M, Varlet P, Peeters A, et al. White matter perivascular spaces: an MRI marker in pathology-proven cerebral amyloid angiopathy? Neurology 2014;82:57-62. https://doi.org/10.1212/01.wnl.0000438225.02729.04
  9. Charidimou A, Jager RH, Peeters A, Vandermeeren Y, Laloux P, Baron JC, et al. White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy. Stroke 2014;45:2930-2935. https://doi.org/10.1161/STROKEAHA.114.005568
  10. Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, Auriel E, Halpin A, Quimby M, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology 2013;80:1551-1556. https://doi.org/10.1212/WNL.0b013e31828f1876
  11. Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci 2007;257:49-55. https://doi.org/10.1016/j.jns.2007.01.013
  12. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012;4:147ra111.
  13. Parlak MM, Babademez MA, Alicura Tokgoz S, Bizpinar O, Saylam G. Evaluation of Swallowing Function according to the Stage of Alzheimer's Disease. Folia Phoniatr Logop 2022;74:186-194. https://doi.org/10.1159/000519263
  14. Munis OB, Parlak MM, Kose A. Analysis of the consistency of information received from Alzheimer's disease patients and their families in the quality of life and depression scales. Turkish Journal of Clinics and Laboratory 2021;12:372-378. https://doi.org/10.18663/tjcl.854945
  15. Parlak MM, Altan E, Saylam G. Dysphagia in Individuals with Dementia. Journal of Ear Nose Throat and Head Neck Surgery 2022:88-96.
  16. Parlak MM, Tokgoz SA, Bizpinar O, Saylam G, Kose A. Investigation of cognition, nutrition, independence and swallowing difficulty, relationship with quality of life, and effect levels in elderly people with Alzheimer's disease living with their families. Neurol Asia 2022;27:701-708. https://doi.org/10.54029/2022eeu
  17. Parlak MM, Bizbinar O, Kose A. The Effect of Holistic Therapy in Alzheimer's Disease. Altern Ther Health Med 2023.29:52-59.
  18. Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 2020;16:30-42. https://doi.org/10.1038/s41582-019-0281-2
  19. de la Torre JC. Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol 2012;2012:367516.
  20. Hansen TP, Cain J, Thomas O, Jackson A. Dilated perivascular spaces in the Basal Ganglia are a biomarker of small-vessel disease in a very elderly population with dementia. AJNR Am J Neuroradiol 2015;36:893-898. https://doi.org/10.3174/ajnr.A4237
  21. Nguyen TT, Ta QT, Nguyen TK, Nguyen TT, Giau VV. Type 3 diabetes and its role implications in Alzheimer's disease. Int J Mol Sci 2020;21:3165.
  22. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012;83:124-137. https://doi.org/10.1136/jnnp-2011-301308
  23. Patankar TF, Mitra D, Varma A, Snowden J, Neary D, Jackson A. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. AJNR Am J Neuroradiol 2005.26:1512-1520.
  24. Chen W, Song X, Zhang Y; Alzheimer's Disease Neuroimaging Initiative. Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging. AJNR Am J Neuroradiol 2011;32:1490-1495. https://doi.org/10.3174/ajnr.A2541
  25. Zlokovic BV. Cerebrovascular disease in Alzheimer's disease. Trends Neurosci 2005;4:202-208. https://doi.org/10.1016/j.tins.2005.02.001
  26. Boespflug EL, Simon MJ, Leonard E, Grafe M, Woltjer R, Silbert LC, et al. Targeted assessment of enlargement of the perivascular space in Alzheimer's disease and vascular dementia subtypes implicates astroglial involvement specific to Alzheimer's disease. J Alzheimers Dis 2018;66:1587-1597. https://doi.org/10.3233/JAD-180367
  27. Huang P, Zhu Z, Zhang R, Wu X, Jiaerken Y, Wang S, et al. Factors associated with the dilation of perivascular space in healthy elderly subjects. Front Aging Neurosci 2021;13:624732.
  28. Brown R, Benveniste H, Black SE, Charpak S, Dichgans M, Joutel A, et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res 2018;114:1462-1473. https://doi.org/10.1093/cvr/cvy113
  29. Saeki N, Sato M, Kubota M, Uchino Y, Murai H, Nagai Y, et al. MR imaging of normal perivascular space expansion at midbrain. AJNR Am J Neuroradiol 2005.26:566-571.
  30. Kim YK, Nam KI, Song J. The glymphatic system in diabetes-induced dementia. Front Neurol 2018;9:867.
  31. Jiang Q, Zhang L, Ding G, Davoodi-Bojd E, Li Q, Li L, et al. Impairment of the glymphatic system after diabetes. J Cereb Blood Flow Metab 2017;37:1326-1337. https://doi.org/10.1177/0271678X16654702
  32. Weller RO, Hawkes CA, Kalaria RN, Werring DJ, Carare RO. White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol 2015;25:63-78. https://doi.org/10.1111/bpa.12218
  33. Elster AD, Richardson DN. Focal high signal on MR scans of the midbrain caused by enlarged perivascular spaces: MR-pathologic correlation. AJNR Am J Neuroradiol 1990;11:1119-1122.
  34. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010;41:450-454. https://doi.org/10.1161/STROKEAHA.109.564914